254 related articles for article (PubMed ID: 29460914)
1. [Alpha-lipoic acid in the treatment of diabetic polyneuropathy].
Chukanova EI; Chukanova AS
Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(1):103-109. PubMed ID: 29460914
[TBL] [Abstract][Full Text] [Related]
2. [α-Lipoic acid as the main pharmacological drug for in- and outpatient treatment of diabetic polyneuropathy].
Strokov IA; Phokina AS
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(3):50-55. PubMed ID: 28399096
[TBL] [Abstract][Full Text] [Related]
3. Thioctic acid for patients with symptomatic diabetic polyneuropathy: a critical review.
Ziegler D
Treat Endocrinol; 2004; 3(3):173-89. PubMed ID: 16026113
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy and safety of high-dose α-lipoic acid in the treatment of diabetic polyneuropathy].
Gu XM; Zhang SS; Wu JC; Tang ZY; Lu ZQ; Li H; Liu C; Chen L; Ning G
Zhonghua Yi Xue Za Zhi; 2010 Sep; 90(35):2473-6. PubMed ID: 21092474
[TBL] [Abstract][Full Text] [Related]
5. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy.
Ziegler D; Hanefeld M; Ruhnau KJ; Hasche H; Lobisch M; Schütte K; Kerum G; Malessa R
Diabetes Care; 1999 Aug; 22(8):1296-301. PubMed ID: 10480774
[TBL] [Abstract][Full Text] [Related]
6. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis.
Ziegler D; Nowak H; Kempler P; Vargha P; Low PA
Diabet Med; 2004 Feb; 21(2):114-21. PubMed ID: 14984445
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacological significance of alpha lipoic acid in up to date treatment of diabetic neuropathy].
Becić F; Kapić E; Rakanović-Todić M
Med Arh; 2008; 62(1):45-8. PubMed ID: 18543755
[TBL] [Abstract][Full Text] [Related]
8. Treatment of diabetic polyneuropathy with alpha-lipoic acid is evidence based.
Vereşiu IA
Rom J Intern Med; 2004; 42(2):293-9. PubMed ID: 15529620
[TBL] [Abstract][Full Text] [Related]
9. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study).
Ziegler D; Hanefeld M; Ruhnau KJ; Meissner HP; Lobisch M; Schütte K; Gries FA
Diabetologia; 1995 Dec; 38(12):1425-33. PubMed ID: 8786016
[TBL] [Abstract][Full Text] [Related]
10. [Diabetic polyneuropathy. Sequential therapy with alpha-lipoic acid passes the general practice test].
Hedding-Eckerich M; Eckert MW
MMW Fortschr Med; 2000 Sep; 142(36):38. PubMed ID: 11021068
[No Abstract] [Full Text] [Related]
11. Clinical experience with thioctacid (thioctic acid) in the treatment of distal symmetric polyneuropathy in Korean diabetic patients.
Hahm JR; Kim BJ; Kim KW
J Diabetes Complications; 2004; 18(2):79-85. PubMed ID: 15120701
[TBL] [Abstract][Full Text] [Related]
12. Predictors of improvement and progression of diabetic polyneuropathy following treatment with α-lipoic acid for 4 years in the NATHAN 1 trial.
Ziegler D; Low PA; Freeman R; Tritschler H; Vinik AI
J Diabetes Complications; 2016 Mar; 30(2):350-6. PubMed ID: 26651260
[TBL] [Abstract][Full Text] [Related]
13. The function of endogenous protective systems in patients with insulin-dependent diabetes mellitus and polyneuropathy: effect of antioxidant therapy.
Strokov IA; Manukhina EB; Bakhtina LY; Malyshev IY; Zoloev GK; Kazikhanova SI; Ametov AS
Bull Exp Biol Med; 2000 Oct; 130(10):986-90. PubMed ID: 11177301
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial.
Ziegler D; Low PA; Litchy WJ; Boulton AJ; Vinik AI; Freeman R; Samigullin R; Tritschler H; Munzel U; Maus J; Schütte K; Dyck PJ
Diabetes Care; 2011 Sep; 34(9):2054-60. PubMed ID: 21775755
[TBL] [Abstract][Full Text] [Related]
15. Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials.
Ziegler D; Reljanovic M; Mehnert H; Gries FA
Exp Clin Endocrinol Diabetes; 1999; 107(7):421-30. PubMed ID: 10595592
[TBL] [Abstract][Full Text] [Related]
16. Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy.
Reljanovic M; Reichel G; Rett K; Lobisch M; Schuette K; Möller W; Tritschler HJ; Mehnert H
Free Radic Res; 1999 Sep; 31(3):171-9. PubMed ID: 10499773
[TBL] [Abstract][Full Text] [Related]
17. Thioctic acid-induced acute cholestatic hepatitis.
Ridruejo E; Castiglioni T; Silva MO
Ann Pharmacother; 2011 Jul; 45(7-8):e43. PubMed ID: 21672886
[TBL] [Abstract][Full Text] [Related]
18. Alpha-Lipoic Acid for Treatment of Diabetic Peripheral Neuropathy.
Bartkoski S; Day M
Am Fam Physician; 2016 May; 93(9):786. PubMed ID: 27175957
[No Abstract] [Full Text] [Related]
19. A current update on the use of alpha lipoic acid in the management of type 2 diabetes mellitus.
Poh ZX; Goh KP
Endocr Metab Immune Disord Drug Targets; 2009 Dec; 9(4):392-8. PubMed ID: 19601918
[TBL] [Abstract][Full Text] [Related]
20. Alpha-lipoic acid in the treatment of autonomic diabetic neuropathy (controlled, randomized, open-label study).
Tankova T; Koev D; Dakovska L
Rom J Intern Med; 2004; 42(2):457-64. PubMed ID: 15529636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
